cyamemazine has been researched along with Substance Withdrawal Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benyamina, A; Bourin, M; Naassila, M | 1 |
| Bourin, M; Dailly, E; Hascöet, M | 1 |
| Dib, M; Garay, RP; Garcia-Acosta, S; Kermadi, I; Lemoine, P | 1 |
| d'Alche-Birée, F; Daoust, M; Legrand, E; Naassila, M | 1 |
2 review(s) available for cyamemazine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Potential role of cortical 5-HT(2A) receptors in the anxiolytic action of cyamemazine in benzodiazepine withdrawal.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Humans; Phenothiazines; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Substance Withdrawal Syndrome | 2012 |
Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome.
Topics: Alcohols; Animals; Anti-Anxiety Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Humans; Pharmacology, Clinical; Phenothiazines; Substance Withdrawal Syndrome | 2004 |
1 trial(s) available for cyamemazine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Benzodiazepines; Bromazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; GABA Modulators; Humans; Male; Middle Aged; Personality Inventory; Phenothiazines; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome; Time Factors | 2006 |
1 other study(ies) available for cyamemazine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice.
Topics: Alcohol Deterrents; Alcohol Drinking; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Central Nervous System Depressants; Eating; Ethanol; Lorazepam; Male; Mice; Motor Activity; Phenothiazines; Rats; Rats, Sprague-Dawley; Seizures; Substance Withdrawal Syndrome; Weight Gain | 1998 |